These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22944190)

  • 1. How to initiate lithium therapy: a systematic review of dose estimation and level prediction methods.
    Sienaert P; Geeraerts I; Wyckaert S
    J Affect Disord; 2013 Mar; 146(1):15-33. PubMed ID: 22944190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive methods versus clinical titration for the initiation of lithium therapy. A systematic review].
    Geeraerts I; Sienaert P
    Tijdschr Psychiatr; 2013; 55(10):761-71. PubMed ID: 24166336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder.
    Hopkins HS; Gelenberg AJ
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):174-9. PubMed ID: 11256684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three simple methods for predicting therapeutic lithium doses.
    Srisurapanont M; Pratoomsri W; Maneeton N
    Psychiatry Res; 2000 Apr; 94(1):83-8. PubMed ID: 10788681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder.
    Gulack BC; Puri NV; Kim WJ
    Ann Pharmacother; 2011 Oct; 45(10):e57. PubMed ID: 21917558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients.
    Abou-Auda HS; Al-Yamani MJ; Abou-Shaaban RR; Khoshhal SI
    Bipolar Disord; 2008 May; 10(3):369-76. PubMed ID: 18402625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lithium treatment in patients with impaired kidney function: Between Scylla and Charybdis].
    Dehning J; Grunze H; Born C; Hausmann A
    Fortschr Neurol Psychiatr; 2017 May; 85(5):288-291. PubMed ID: 28561179
    [No Abstract]   [Full Text] [Related]  

  • 8. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?
    Fountoulakis KN; Vieta E; Bouras C; Notaridis G; Giannakopoulos P; Kaprinis G; Akiskal H
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):269-87. PubMed ID: 17506922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Cockcroft-Gault method to estimate lithium dosage requirement.
    Chiu CC; Shen WW; Chen KP; Lu ML
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):269-74. PubMed ID: 17472595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lithium levels need to be monitored: discrepancies between guidelines and practice].
    van de Beek LM; Ouwens MA; de Vries PL; Hummelen JW
    Tijdschr Psychiatr; 2010; 52(6):367-73. PubMed ID: 20544594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial Photobiomodulation to Augment Lithium in Bipolar-I Disorder.
    Mannu P; Saccaro LF; Spera V; Cassano P
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):577-578. PubMed ID: 31532306
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving tolerability of lithium with a once-daily dosing schedule.
    Singh LK; Nizamie SH; Akhtar S; Praharaj SK
    Am J Ther; 2011 Jul; 18(4):288-91. PubMed ID: 20592663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated review of the optimal lithium dosage regimen for renal protection.
    Carter L; Zolezzi M; Lewczyk A
    Can J Psychiatry; 2013 Oct; 58(10):595-600. PubMed ID: 24165107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lithium, a potentially dangerous drug].
    Dhondt AD
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1017; author reply 1018-9. PubMed ID: 15903045
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Collumbien EC
    Ned Tijdschr Geneeskd; 2000 May; 144(21):1022-3. PubMed ID: 10858795
    [No Abstract]   [Full Text] [Related]  

  • 17. Starting lithium prophylaxis early v. late in bipolar disorder.
    Kessing LV; Vradi E; Andersen PK
    Br J Psychiatry; 2014 Sep; 205(3):214-20. PubMed ID: 25012681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.